As trendy weightloss drugs change eating habits, food manufacturers are trying their best to cash in. Choi_ Nikolai - stock.adobe.com They’re not biting. As Ozempic and other GLP-1 drugs change ...
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss drug ...
Results that may be inaccessible to you are currently showing.